| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-974
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-815 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56 |
| filingDate |
2006-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2008-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2008530992-A |
| titleOfInvention |
Method for measuring total coagulation activity of blood or plasma samples |
| abstract |
A method for measuring the maximum activation ability of thrombin in blood or plasma is provided. A highly specific and non-irreversible amount of thrombin inhibitor is added to a blood or plasma sample to induce clotting of the blood or plasma sample, and consumption of the added thrombin inhibitor after a certain period of time A kit for obtaining information on the coagulation state of a blood sample, and a method for measuring the total coagulation activity of a blood or plasma sample, characterized in that the amount is measured by a method known per se. [Selection] Figure 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016170944-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11078518-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10302626-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014050926-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014050926-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017106925-A |
| priorityDate |
2005-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |